115 related articles for article (PubMed ID: 3244205)
1. Amelioration of experimental amnesia (passive avoidance failure) in rodents by the selective M1 agonist AF102B.
Nakahara N; Iga Y; Mizobe F; Kawanishi G
Jpn J Pharmacol; 1988 Dec; 48(4):502-6. PubMed ID: 3244205
[TBL] [Abstract][Full Text] [Related]
2. Beneficial effects of FKS-508 (AF102B), a selective M1 agonist, on the impaired working memory in AF64A-treated rats.
Nakahara N; Iga Y; Saito Y; Mizobe F; Kawanishi G
Jpn J Pharmacol; 1989 Dec; 51(4):539-47. PubMed ID: 2615046
[TBL] [Abstract][Full Text] [Related]
3. (+-)-cis-2-methyl-spiro(1,3-oxathiolane-5,3')quinuclidine, an M1 selective cholinergic agonist, attenuates cognitive dysfunctions in an animal model of Alzheimer's disease.
Fisher A; Brandeis R; Karton I; Pittel Z; Gurwitz D; Haring R; Sapir M; Levy A; Heldman E
J Pharmacol Exp Ther; 1991 Apr; 257(1):392-403. PubMed ID: 2019998
[TBL] [Abstract][Full Text] [Related]
4. Effects of a novel cholinergic M1 agonist, AF102B, on ambulation and water drinking behavior in rats.
Togashi H; Matsumoto M; Yoshioka M; Saito Y; Saito H
Hokkaido Igaku Zasshi; 1991 Jan; 66(1):59-66. PubMed ID: 2004736
[TBL] [Abstract][Full Text] [Related]
5. Central muscarinic activities of an M1-selective agonist: preferential effect on reversal of amnesia.
Nakahara N; Fujise N; Kawanishi G; Mizobe F
Brain Res; 1990 Jan; 507(1):172-5. PubMed ID: 2302575
[TBL] [Abstract][Full Text] [Related]
6. (+-)-cis-2-methyl-spiro(1,3-oxathiolane-5,3') quinuclidine (AF102B): a new M1 agonist attenuates cognitive dysfunctions in AF64A-treated rats.
Fisher A; Brandeis R; Pittel Z; Karton I; Sapir M; Dachir S; Levy A; Heldman E
Neurosci Lett; 1989 Jul; 102(2-3):325-31. PubMed ID: 2812509
[TBL] [Abstract][Full Text] [Related]
7. Effects of a M1 muscarinic receptor agonist on the central cholinergic system, evaluated by brain microdialysis.
Ogane N; Takada Y; Iga Y; Kawanishi G; Mizobe F
Neurosci Lett; 1990 Jun; 114(1):95-100. PubMed ID: 2381577
[TBL] [Abstract][Full Text] [Related]
8. Heterogeneity of muscarinic autoreceptors and heteroreceptors in the rat brain: effects of a novel M1 agonist, AF102B.
Ono S; Saito Y; Ohgane N; Kawanishi G; Mizobe F
Eur J Pharmacol; 1988 Oct; 155(1-2):77-84. PubMed ID: 3243333
[TBL] [Abstract][Full Text] [Related]
9. Effects of sustained release formulation of thyrotropin-releasing hormone on learning impairments caused by scopolamine and AF64A in rodents.
Miyamoto M; Hirai K; Takahashi H; Kato K; Nishiyama M; Okada H; Nagaoka A
Eur J Pharmacol; 1993 Jul; 238(2-3):181-9. PubMed ID: 8405091
[TBL] [Abstract][Full Text] [Related]
10. Cholinergic drugs reverse AF64A-induced impairment of passive avoidance learning in rats.
Yamazaki N; Kato K; Kurihara E; Nagaoka A
Psychopharmacology (Berl); 1991; 103(2):215-22. PubMed ID: 2027921
[TBL] [Abstract][Full Text] [Related]
11. A comparison of the effects of the novel muscarinic receptor agonists L-689,660 and AF102B in tests of reference and working memory.
Dawson GR; Bayley P; Channell S; Iversen SD
Psychopharmacology (Berl); 1994 Jan; 113(3-4):361-8. PubMed ID: 7862846
[TBL] [Abstract][Full Text] [Related]
12. Reversal of age-related cognitive impairments by an M1 cholinergic agonist, AF102B.
Brandeis R; Dachir S; Sapir M; Levy A; Fisher A
Pharmacol Biochem Behav; 1990 May; 36(1):89-95. PubMed ID: 2349275
[TBL] [Abstract][Full Text] [Related]
13. Modulation of rhythmical slow activity, long-term potentiation and memory by muscarinic receptor agonists.
Iga Y; Arisawa H; Ise M; Yasuda H; Takeshita Y
Eur J Pharmacol; 1996 Jul; 308(1):13-9. PubMed ID: 8836627
[TBL] [Abstract][Full Text] [Related]
14. Sympathoexcitatory action of a novel muscarinic receptor agonist, AF102B, and its blockade by pirenzepine.
Yoshioka M; Togashi H; Matsumoto M; Morii K; Saito H
Pharmacol Toxicol; 1990 Jul; 67(1):84-7. PubMed ID: 2395822
[TBL] [Abstract][Full Text] [Related]
15. Impairment of spatial working memory of rats in radial maze performance induced by ethylcholine mustard aziridinium picrylsulfonate (AF64A-P): retention curve analysis.
Inagawa K
Nihon Shinkei Seishin Yakurigaku Zasshi; 1994 Feb; 14(1):9-17. PubMed ID: 8048282
[TBL] [Abstract][Full Text] [Related]
16. Effects of AF102B and tacrine on delayed match-to-sample in monkeys.
O'Neill J; Fitten LJ; Siembieda D; Halgren E; Kim E; Fisher A; Perryman K
Prog Neuropsychopharmacol Biol Psychiatry; 1998 May; 22(4):665-78. PubMed ID: 9682279
[TBL] [Abstract][Full Text] [Related]
17. [Effect of a muscarinic (M1) receptor agonist on sympathetic nerve activity in rats].
Saito Y
Hokkaido Igaku Zasshi; 1993 Mar; 68(2):190-204. PubMed ID: 8509063
[TBL] [Abstract][Full Text] [Related]
18. Effect of YM796, a novel muscarinic agonist, on the impairment of passive avoidance response in senescence-accelerated mice.
Suzuki M; Yamaguchi T; Ozawa Y; Iwai A; Yamamoto M
Pharmacol Biochem Behav; 1995 Aug; 51(4):623-6. PubMed ID: 7675834
[TBL] [Abstract][Full Text] [Related]
19. NGF-dependent neurotrophic-like effects of AF102B, an M1 muscarinic agonist, in PC12M1 cells.
Gurwitz D; Haring R; Pinkas-Kramarski R; Stein R; Heldman E; Karton Y; Fisher A
Neuroreport; 1995 Feb; 6(3):485-8. PubMed ID: 7766849
[TBL] [Abstract][Full Text] [Related]
20. AF102B, a muscarinic M1 receptor agonist, mimics some effects of acetylcholine on neurons of rat hippocampus slices.
Segal M; Fisher A
Eur J Pharmacol; 1992 Sep; 220(1):103-6. PubMed ID: 1425975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
